How I Treat Newly Diagnosed, Relapsed and Transformed CLL Patients

Description

How I Treat Newly Diagnosed, Relapsed, and Transformed CLL Patients Upon viewing this session, you will be able to:
• Discuss the rapidly changing data supporting the use of novel targeted therapies in the frontline treatment of CLL
• Identify current data supporting the use of novel targeted therapies in relapsed/refractory CLL
• Identify current cellular immuno-therapies available for management of relapsed/refractory CLL
• Update the management of Richter’s transformation

Presenters

  • Jose Leis, MD, PhD, Mayo Clinic

Pricing

Member Type Price
List Price $30.00
Active, International, Emeritus, and Honorary Members $20.00
Associate, International Associate, Student, and Resident Members $20.00
back to top